PacBio sequencing reagents

The National Institutes of Health (NIH) is seeking to award a Firm-Fixed-Price Purchase Order to Pacific Biosciences of California, Inc. for PacBio sequencing reagents. The NIH Intramural Sequencing Center (NISC) requires these reagents to meet sequencing demands, and they must be compatible with the Pacific Biosciences Revio sequencer. • The reagents include SMRT cells and sequencing reagents that are specially configured for the instrument and the requirements of a run. • Library reagents include specialized adapters and enzymes that are proprietary to Pacific Biosciences. • The notice is not a request for competitive quotes, but small businesses may submit a written capability statement to demonstrate their ability to perform the requirement. • An award will be issued approximately ten days after the date of the notice unless the Government determines that another vendor has the capability to meet this requirement.